DENVER, CO
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)GLOBAL DOWN SYNDROME FOUNDATION, founded in 2009, is a community nonprofit in the Health Care sector that reported $4.7M in total revenue in fiscal year 2024. Revenue grew 9% year-over-year, indicating healthy expansion.
TO SIGNIFICANTLY IMPROVE THE LIVES OF PEOPLE WITH DOWN SYNDROME THROUGH RESEARCH, MEDICAL CARE, EDUCATION AND ADVOCACY. AN IMPORTANT PART OF THIS MISSION IS TO SUPPORT THE GLOBAL AFFILIATE ORGANIZATIONS THAT WE HELPED ESTABLISH AND CONTINUE TO FUNDRAISE FOR. GLOBAL AND OUR AFFILIATES WORK TOGETHER TO ELONGATE LIFE AND DRAMATICALLY IMPROVE HEALTH OUTCOMES TO ENSURE PEOPLE WITH THE CONDITION CAN REACH THEIR TRUE POTENTIAL. GLOBAL AFFILIATES INCLUDE: CRNIC INSTITUTE FOR DOWN SYNDROME, ALZHEIMER'S & COGNITION CENTER, SIE CENTER FOR DOWN SYNDROME, AND GLOBAL ADULT CLINIC. ANOTHER IMPORTANT PART OF OUR MISSION IS TO ENGAGE IN GOVERNMENT ADVOCACY THAT LEADS TO TRANSFORMATIVE INCREASES IN GOVERNMENT FUNDING FOR DOWN SYNDROME RESEARCH AND MEDICAL CARE WHICH IN TURN WILL CREATE A PIPELINE OF YOUNG TALENT DEDICATED TO THIS POPULATION. BECAUSE OF GLOBAL'S WORK, SCIENTISTS ARE DEVELOPING BETTER METHODS TO UNDERSTAND HOW THE TRIPLICATION LEADS TO A MUCH HIGHER INCIDENCE OF CERTAIN DISEASES (FOR EXAM
RESEARCH AND CLINICAL CARE: DOWN SYNDROME IS WHEN A PERSON IS BORN WITH THREE COPIES OF CHROMOSOME 21 INSTEAD OF THE USUAL TWO. BEFORE GLOBAL WAS ESTABLISHED, DOWN SYNDROME WAS THE LEAST FUNDED...
RESEARCH AND CLINICAL CARE: DOWN SYNDROME IS WHEN A PERSON IS BORN WITH THREE COPIES OF CHROMOSOME 21 INSTEAD OF THE USUAL TWO. BEFORE GLOBAL WAS ESTABLISHED, DOWN SYNDROME WAS THE LEAST FUNDED GENETIC CONDITION BY THE NATIONAL INSTITUTES OF HEALTH (NIH) AND VERY LITTLE WAS BEING DONE TO INCREASE RESEARCH OR CREATE EVIDENCE-BASED MEDICAL CARE GUIDELINES. -GLOBAL ESTABLISHED THE FIRST DOWN SYNDROME RESEARCH AND MEDICAL CARE INSTITUTE IN OUR COUNTRY - OUR AFFILIATE, THE CRNIC INSTITUTE FOR DOWN SYNDROME. -GLOBAL ESTABLISHED ONE OF THE LARGEST DOWN SYNDROME MEDICAL CENTERS IN THE WORLD SERVING 2,500+ CHILDREN WITH DOWN SYNDROME FROM 35 STATES AND 11 COUNTRYS - OUR AFFILIATE THE SIE CENTER FOR DOWN SYNDROME. -GLOBAL SUCCESSFULLY LOBBIED AND ADVOCATED FOR THE ESTABLISHMENT OF THE TRANS-NIH DOWN SYNDROME RESEARCH PROGRAM CALLED "INCLUDE- AND HAVE LED TO THE RENAISSANCE OF DOWN SYNDROME RESEARCH TODAY. -GLOBAL SUCCESSFULLY LOBBIED AND ADVOCATED FOR THE NATIONAL INSTITUTES OF AGING TO LAUNCH THEIR LONGITUDINAL AD-DS BIOMARKER GRANTS. -GLOBAL CREATED THE FIRST EVIDENCED-BASED GLOBAL MEDICAL CARE GUIDELINES FOR ADULTS WITH DOWN SYNDROME PUBLISHED IN THE JOURNAL OF AMERICAN MEDICAL JOURNAL (JAMA) -GLOBAL ESTABLISHED THE BE BEAUTIFUL BE YOURSELF FASHION SHOW, THE WORLD'S LARGEST FUNDRAISER BENEFITTING PEOPLE WITH DOWN SYNDROME AND THE ACCEPTABILITY GALA, THE FIRST DOWN SYNDROME RESEARCH FUNDRAISER IN WASHINGTON DC, -GLOBAL ORGANIZED THE: FIRST DOWN SYNDROME RESEARCH SUMMIT IN THE US IN 2006 HEADED BY NOBEL LAUREATE TOM CECH FIRST DOWN SYNDROME RESEARCH CONFERENCE AT NIH IN 2010 FOCUSED ON DATABASES, BIOBANKS & REGISTRIES WHICH RESULTED IN NIH CREATING THE DSCONNECTS DOWN SYNDROME REGISTRY FIRST DOWN SYNDROME & ALZHEIMER'S DISEASE WORKSHOP IN COLLABORATION WITH THE ALZHEIMER'S ASSOCIATION AND NIA IN 2012 FIRST DOWN SYNDROME & ALZHEIMER'S DISEASE RESEARCH GRANTS CO-FUNDED BY GLOBAL AND THE ALZHEIMER'S ASSOCIATION. GLOBAL IS DELIVERING ON OUR MISSION THROUGH GROUNDBREAKING RESEARCH WITH OUR AFFILIATES. FOR EXAMPLE WE HAVE: - DISCOVERED THAT DOWN SYNDROME IS AN IMMUNE SYSTEM DISORDER AND WE HAVE CONDUCTED TWO CLINICAL TRIALS TESTING DRUGS THAT NORMALIZE THE IMMUNE SYSTEM AND HAVE HAD PROFOUND RESULTS; WE ARE CURRENTLY ORGANIZING A 3RD SUCH CLINICAL TRIAL - HOLD AN NIH INCLUDE CLINICAL TRIAL GRANT AIMED AT EFFECTIVELY TREATING DOWN SYNDROME REGRESSION DISORDER - DISCOVERED THAT PEOPLE WITH DOWN SYNDROME ARE HYPOXIC - DISCOVERED THREE DISTINCT PHENOTYPES IN DOWN SYNDROME THAT COULD LEAD TO MORE EFFECTIVE "PRECISION MEDICINE" - SUPPORTED THE FIRST CLINICAL TRIALS TESTING PROMISING ALZHEIMER'S DRUGS IN PEOPLE WITH DOWN SYNDROME - PUBLISHED "THE" BEHAVIORAL GUIDELINES FOR CHILDREN WITH DOWN SYNDROME - CREATED A RUBRIC FOR TEST CHILDREN WITH DOWN SYNDROME FOR DYSPHAGIA - PUBLISHED GROUNDBREAKING NATURAL HISTORY STUDIES IN INFANTILE SPASMS, PHYSICAL THERAPY, NEUROLOGY AND MORE.
OUTREACH, EDUCATION, AND CONFERENCES: GLOBAL OFFERS A VARIETY OF RESEARCH AND MEDICAL OUTREACH MEETINGS, WORKSHOPS, WEBINARS, EDUCATIONAL PROGRAMS, AND CLASSES DESIGNED TO SUPPORT AND IMPROVE THE...
OUTREACH, EDUCATION, AND CONFERENCES: GLOBAL OFFERS A VARIETY OF RESEARCH AND MEDICAL OUTREACH MEETINGS, WORKSHOPS, WEBINARS, EDUCATIONAL PROGRAMS, AND CLASSES DESIGNED TO SUPPORT AND IMPROVE THE LIVES OF GLOBAL 'S SELF- ADVOCATES, FAMILY MEMBERS AND PROFESSIONALS SERVING OUR COMMUNITY. MANY OF OUR EDUCATIONAL PROGRAMS INVOLVE BUILDING SKILLS, BUILDING SELF-ESTEEM AND FOSTERING INDEPENDENCE.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $4,716,290 | $4,313,796 | +0.1% |
| Expenses | $4,697,476 | $4,670,703 | +0.0% |
| Net Income | $18,814 | $-356,907 | -1.1% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| MICHELLE SIE WHITTEN | PRESIDENT AN | 20.00 |
Officer
Director
|
$154,756 | $37,764 | $347,276 |
| JOHN J SIE | CHAIR | 1.50 |
Officer
Director
|
$0 | $0 | $0 |
| MARY BETH WALLINGFORD | TREASURER | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| RICHARD WAYSDORF | SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| JOHN C MCGINLEY | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JAY MILLS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| RICKI REST | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| TOMAGO COLLINS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| CHARLIE MONFORT | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| FRANK STEPHENS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| PETER KUDLA | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JAMIE NIELSEN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $4,716,290 | $4,697,476 | $8,688,920 | $18,814 |
| 2024 | $4,313,796 | $4,670,703 | $8,646,012 | $-356,907 |
| 2023 | $3,826,365 | $3,562,334 | $9,055,430 | $264,031 |
| 2022 | $946,045 | $1,207,187 | $8,604,160 | $-261,142 |
| 2021 | $3,228,128 | $2,669,185 | $8,253,735 | $558,943 |
| 2020 | $3,586,993 | $2,924,422 | $7,860,291 | $662,571 |
| 2019 | $3,703,167 | $3,329,779 | $7,622,270 | $373,388 |
| 2018 | $4,769,092 | $4,048,136 | $7,089,904 | $720,956 |
Compare GLOBAL DOWN SYNDROME FOUNDATION with other nonprofits in Colorado and across the country.